Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas

Cancer Research

Volumn 59, Issue 21, 1999, Pages 5536-5541

  Angelov, Lilyana ^b,c   Salhia, Bodour ^c   Roncari, Luba ^c   McMahon, Gerald ^d   Guha, Abhijit ^a,b,c  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d SUGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; SEMAXANIB; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INHIBITION; CANCER RECURRENCE; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; NEUROFIBROSARCOMA; PRIORITY JOURNAL; TUMOR GROWTH; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CHEMOTHERAPY, ADJUVANT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL GROWTH FACTORS; ENZYME INHIBITORS; INDOLES; LYMPHOKINES; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NEUROFIBROMATOSIS 1; NEURONS; PYRROLES; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SARCOMA; TIME FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033229939     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Crowe, F. W., Schull, W. T., and Neel, J. F. A Clinical, Pathological, and Genetic Study of Multiple Neurofibromatosis. Springfield, IL: Charles C. Thomas, 1956.
2. Angelov, L., Davis, A., O'Sullivan, B., Bell, R., and Guha, A. Neurogenic sarcomas: experience at the University of Toronto. Neurosurgery, 43: 56-65, 1998.
3. Folkman, J., and Shing, Y. Angiogenesis. J. Biol. Chem., 267: 10931-10934, 1992.
4. Hori, A., Sasada, R., Matsutani, E., Naito, K., Sakura, Y., Fujita, T., and Kozai, Y. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res., 51: 6180-6184, 1991.
5. Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362: 841-844, 1993.
6. Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367: 576-579, 1994.
7. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285: 1182-1186, 1971.
8. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
9. Alon, T., Hemo, I., Itin, A., Peer, J., Stone, J., and Keshet, E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med., 1: 1024-1028, 1995.
10. Keck, P. J., Hauser, S., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Conolly, D. T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (Washington DC), 246: 1309-1312, 1989.
11. Conolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Investig., 84: 1470-1478, 1989.
12. Esser, S., Wolburg, K., Breier, G., Kurzchalia, T., and Risau, W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol., 140: 947-959, 1998.
13. Roberts, W. G., and Palade, G. E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res., 57: 765-772, 1997.
14. Plate, K. H., Breier, G., Weich, H. A., and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond.), 359: 845-848, 1992.
15. Yoshiji, H., Gomez, D. E., Shibuya, M., and Thorgeirsson, U. P. Expression of vascular endothelial growth factor, its receptor and other angiogenic factors in breast cancer. Cancer Res., 56: 2013-2016, 1996.
16. Samoto, K., Ikezaki, K., Ono, M., Shono, T., Kimitoshi, K., Kuwano, M., and Fukui, M. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res., 55: 1189-1193, 1995.
17. Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes up-regulate VEGF/VPF expression: implications of induction and inhibition of tumor angiogenesis. Cancer Res., 55: 4575-4580, 1995.
18. Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and Dvorak, H. F. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53: 4727-4735, 1993.
19. Claffey, K. P., Brown, L. F., del Aguila, L. F., Tognazzi, K., Yeo, K-T., Manseau, E. J., and Dvorak, H. F. Expression of vascular permeability/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res., 56: 172-181, 1996.
20. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marme, D. Both v-Ha-ras and v-raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells. J. Biol. Chem., 270: 25915-25919, 1995.
21. Feldkamp, M. M., Lau, N., Rak, J., Kerbel, R. S., and Guha, A. Normoxic and hypoxic regulation of vascular endothelial growth factor (VEGF) by astrocytoma cells is mediated by ras. Int. J. Cancer, 81: 118-124, 1999.
22. Li, J., Perrella, M. A., Tsai, J. C., Yet, S. F., Hsieh, C. M., Yoshizumi, M., Patterson, C., Endege, W. O., Zhou, F., and Lee, M. E. Induction of vascular endothelial growth factor gene expression by interleukin-1β in rat aortic smooth muscle cells. J. Biol. Chem., 270: 308-312, 1995.
23. Cohen, T., Nahari, D., Cerem-Weiss, L., Neufeld, G., and Levi, B. Interleukin-6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271: 736-741, 1996.
24. Deroanne, C. F., Hajitou, A., Calberg-Bacq, C. M., Nusgens, B. V., and Lapiere, C. M. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression. Cancer Res., 57: 5590-5597, 1997.
25. Finkenzeller, G., Sparacio, A., Technau, A., Marme, D., and Seimeister, G. Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene, 15: 669-676, 1997.
26. Ryuto, M., Ono, M., Izumi, H., Yoshida, S., Weich, H. A., Kohno, K., and Kuwano, M. Induction of vascular endothelial growth factor by tumor necrosis factor α in human glioma cells: possible roles of SP-1. J. Biol. Chem., 271: 28220-28228, 1996.
27. Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J. Biol. Chem., 269: 6271-6274, 1994.
28. Frank, S., Hubner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., and Werner, S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes: implications for normal and impaired wound healing. J. Biol. Chem., 270: 12607-12613, 1995.
29. Goad, D. L., Rubin, J., Wang, H., Tashjian, A. H., and Patterson, C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology, 137: 2262-2268, 1996.
30. Kieser, A., Welch, H. A., Brandner, G., Marme, D., and Kolch, W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene, 9: 963-969, 1994.
31. Adamis, A. P., Shima, D. T., Yeo, K-T., Yeo, T-K., Brown, L. F., Berse, B., D'Amore, P. A., and Folkman, J. Synthesis and secretion of vascular permiability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun., 193: 631-638, 1993.
32. Finkenzeller, G., Technau, A., and Marmé, D. Hypoxia induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem. Biophys. Res. Commun., 208: 432-439, 1995.
33. Goldberg, M. A., and Schneider, T. J. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem., 269: 4355-4359, 1994.
34. Levy, A. P., Levy, N. S., and Goldberg, M. A. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J. Biol. Chem., 271: 2746-2753, 1996.
35. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
36. De Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC), 255: 989-991, 1992.
37. Risau, W., and Flamme, I. Vasculogenesis. Annu. Rev. Cell Dev. Biol., 11: 73-91, 1995.
38. Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., and Armellino, D. C. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187: 1579-1586, 1993.
39. Matthews, W., Jordan, C. T., Weigand, G. W., Pardoll, D., and Lemischka, I. R. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell enriched populations. Cell, 65: 1143-1152, 1991.
40. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family. Oncogene, 5: 519-524, 1990.
41. Waltenberger, J., Claesson-Welsh, L., Siegnahn, A., Shibuya, S., and Heldin, C-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269: 26988-26995, 1994.
42. Zachary, I. Vascular endothelial growth factor. Int. J. Biochem. Cell Biol., 30: 1169-1174, 1998.
43. Millauer, B., Wizigmann Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ulrich, A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72: 835-846, 1993.
44. Rockwell, P., Neufeld, G., Glassman, A., Caron, D., and Goldstein, N. In vitro neutralization of vascular endothelial growth factor activation of Flk-1 by a monoclonal antibody. Mol. Cell. Differ., 3: 91-109, 1995.
45. Cushman, C., Escobedo, J. A., Parry, T. J., Kisich, K. O., Richardson, M. L., Speirer, K. S., Scherrer, J., McSwiggen, J., Maloney, L., DiRenzo, A., Mokler, V. R., Wincott, F. E., and Pavco, P. A. Ribozyme inhibition of VEGF-mediated endothelial cell proliferation in cell culture and VEGF-induced angiogenesis in a rat corneal model. In: Angiogenesis Inhibitors and Other Novel Strategies for Ocular Diseases of Neovascularization. International Business Communications, 1996.
46. Saleh, M., Stacker, S. A., and Wilks, A. F. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56: 393-401, 1996.
47. Fletcher, J. A., Kozakewich, H. P., Hoffer, F. A., Lage, J. M., Weidner, N., Tepper, R., Pinkus, G. S., Morton, C. C., and Corson, J. M. Diagnostic relevance of clonal cytogenelic aberrations in malignant soft-tissue tumors. N. Engl. J. Med., 324: 436-442, 1991.
48. Glover, T. W., Stein, C. K., Leagues, E., Anderson, L. B., Brereton, A., and Johnson, S. Molecular and cytogenetic analysis of tumors in von Recklinghausen neurofibromatosis. Genes Chromosomes Cancer, 3: 62-70, 1991.
49. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65: 55-63, 1983.
50. Rijken, P. F. J. W., Bernsen, H. J. J. A., and van der Kogel, A. J. Application of an image analysis system to the quantitation of tumor perfusion and vascularity in human glioma xenografts. Microvasc. Res., 50: 141-153, 1995.
51. Toi, M., Hoshina, S., Takayanagi, T., and Tominaga, T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn. J. Cancer Res., 85: 1045-1049, 1994.
52. Anan, K., Morisaki, T., Katano, M., Ikubo, A., Kitsuki, H., Uchiyama, A., Kuroki, S., Takana, M., and Torisu, M. Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer. Surgery, 119: 333-339, 1996.
53. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
54. Takahashi, Y., Sasaki, H., Kim, S. J., Tobisu, K., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., and Terada, M. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placental growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res., 54: 4233-4237, 1994.
55. Cawthon, R. M., Weiss, R., Xu. G., Viskochil, D., Culver, M., Stevens, J., Robertson, M., Dunn, D., Gesteland, R., O'Connell, P., and White, R. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell, 62: 193-201, 1990.
56. Viskochil, D., Buchberg, A. M., Xu, G., Cawthon, R. M., Stevens, J., Wolff, R. K., Culver. M., Carey, J. C., Copeland, N. G., Jenkins, N. A., White, R., and O'Connell, P. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell, 62: 187-192, 1990.
57. Wallace, M. R., Marchuk, D. A., Andersen, L. B., Letcher, R., Odeh, H., Saulino, A. M., Fountain, J. W., Brereton, A., Nicholson, J., Mitchell, A. L., Brownstein, B. H., and Collins, F. S. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NFI patients. Science (Washington DC), 249: 181-186, 1990.
58. Colman, S. D., Williams, C. A., and Wallace, M. R. Benign neurofibromas in type 1 neurofibromatosis (NFI) show somatic deletions of the NFI gene. Nat. Genet., 11: 90-92, 1995.
59. Guha, A., Lau, N., Huvar, I., Gutmann, D. H., Provias, J., Pawson, T., and Boss, G. Ras-GTP levels are elevated in human NF-1 peripheral nerve tumors. Oncogene, 12: 507-513, 1996.
60. Basu, T. N., Gutmann, D. H., Fletcher, J. A., Glover, T. W., Collins, F. S., and Downward, J. Aberrant regulation of ras proteins in malignant tumor cells from type 1 neurofibromatosis patients. Nature (Lond.), 356: 713-715, 1992.
61. Feldkamp, M. M., Lau, N., Provius, J., and Guha, A. Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1 : a pathological and molecular explanation. J. Neurosurg., 84: 867-873, 1996.
62. Legius, E., Marchuk, D. A., Collins, F. S., and Glover, T. W. Somatic deletions of the neurofibromatosis type 1 gene in a neurofibrosarcoma patient supports the tumor suppressor hypothesis. Nat. Genet., 3: 122-126, 1993.
63. Folkman, J., and Klagsbrun, M. Angiogcnic factors. Science (Washington DC), 235: 442-447, 1987.
64. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.), 339: 58-61, 1989.
65. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
66. Kandel, J., Bossy-Welzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D. Neovascularization is associated with a switch to the export of bFGF in the multistep developmenl of fibrosarcoma. Cell, 66; 1095-1104, 1991.
67. Hamada, J., Cavanaugh, P. G., Lotan, O., and Nicolson, G. L. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis. Br. J. Cancer, 66: 349-354, 1992.
68. Nicosia, R. F., Tchao, R., and Leighton, J. Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture. Clin. Exp. Metastasis, 4: 91-104, 1986.
69. Fong, T. A. T., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T. J., Kim, Y. H., Schreck, R., Wang, X., Risau, W., Ullrich, A., Hirth, K. P., and McMahon, G. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res., 59: 99-106, 1999.